Abstract
Although liquid biopsies offer many advantages over tissue biopsies, they are not yet standard practice. An important reason for the lack of implementation is the unavailability of well standardized techniques and guidelines, especially for pre-analytical conditions which are an important factor causing the current sensitivity issues. To overcome these limitations, we investigated the effect of several pre-analytical conditions on the concentration of cell-free DNA (cfDNA) and cellular genomic DNA (gDNA) contamination. Urine samples from healthy volunteers (HVs) and cancer patients were collected and processed according to specific pre-analytical conditions. Our results show that in samples with a relatively small volume more than 50% of the cfDNA can be found in the first 50 mL of the urine sample. The total DNA concentration increased again when samples were collected more than 3.5 hours apart. Adding preservative to urine samples is recommended to obtain high concentrations of cfDNA. To remove the cellular content, high speed centrifugation protocols as 4,000g 10min or 3,000g 15min are ideal for urine collected in cfDNA Urine Preserve (Streck). Although this study was a pilot study and needs to be confirmed in a larger study population, clear trends in the effect of several pre-analytical conditions were observed.
Highlights
The first experiment focused on the variation of cell-free DNA (cfDNA) and genomic DNA (gDNA) content released within one urine sample
Similar to the total DNA concentrations measured with Qubit and Digital droplet PCR (ddPCR), only a minority of the cfDNA was present in the first 50 mL of the total collection of urine (334.5 mL) from HV1
We have investigated several pre-analytical conditions in order to establish some good practice guidelines on the use of urine samples for cfDNA analysis in the management of cancer patients
Summary
To increase sensitivity of urine analysis, the aim of this study was to study the influence of different pre-analytical conditions on the concentration of cfDNA and genomic DNA. We aimed to identify a centrifugation protocol for urine samples that efficiently removes the cellular components without any loss of cfDNA. The purpose of this study was to examine different pre-analytical conditions to create an optimal workflow for urine sample processing
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.